Ikarian Capital »

Springworks Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 44k 32.04
2023-09-30 $4.1M 178k 23.12

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Springworks Therapeutics

Vanguard Group
BlackRock
BlackRock
Deep Track Capital
T. Rowe Price Associates
Boxer Capital
State Street Corporation
Maverick Capital
Marshall Wace
Pictet Asset Management Holding SA
Geode Capital Management
Arrowpoint Asset Management
OrbiMed Advisors
Woodline Partners
Siren

View all funds holding Springworks Therapeutics